Organization
Integra Connect
14 abstracts
Abstract
Adopting combination machine learning models could reduce hospital length of stay for oncology patients.Org: Integra Connect, West Palm Beach, Flare Therapeutics, Bengaluru, Indiana University School of Medicine,
Abstract
The benefit of chart curation of electronic health record (EHR) data: Comparing data completeness between curated and structured data.Org: Integra Connect PrecisionQ, Integra Connect,
Abstract
Real-world data comparison of time to next treatment for patients with HER2 low metastatic treated with either chemotherapy or fam-trastuzumab deruxtecan-nxki following chemotherapy in the metastatic setting.Org: University of Pittsburgh Medical Center (UPMC), Integra Connect PrecisionQ, Highlands Oncology Group, South Carolina Oncology Associates, Integra Connect,
Abstract
Real-world KRAS testing and treatment utilization among patients with metastatic non-small cell lung cancer.Org: Integra Connect PrecisionQ, Integra Connect,
Abstract
Understanding differences in the rates of BRCA/HRD testing and treatment in 1st line maintenance in patients with ovarian cancer treated by gynecologic oncologists compared to other providers: A quality initiative by Integra Connect (IC) PrecisionQ.Org: South Carolina Oncology Associates, Integra Connect PrecisionQ, Integra Connect,
Abstract
Data driven insights from multiple OCM practices to optimize care for managing high-risk cancer patients across multiple cancer types.Org: Integra Connect, Everett Castle, LLC,
Abstract
The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).Org: Yale School of Medicine, Everett Castle, LLC, Integra Connect, Yale University,
Abstract
Use of poly (adp-ribose) polymerase inhibitors (PARPi) in metastatic castration resistant prostate cancer (mCRPC) patients stratified by homologous recombination repair mutations.Org: University of Pittsburgh Medical Center, Integra Connect PrecisionQ, UPMC Hillman Cancer Center, Integra Connect, Illumina, Inc.,
Abstract
Management and treatment of patients with stage III unresected NSCLC at UPMC: A quality initiative by Integra Connect Precision Q.Org: University of Pittsburgh Cancer Institute, Integra Connect PrecisionQ, Integra Connect, UPMC Hillman Cancer Center,
Abstract
PARPi monotherapy as first-line maintenance following chemotherapy + bevacizumab in advanced ovarian cancer.Org: South Carolina Oncology Associates, Precision Q, Integra Connect, GSK Research and Development Upper Providence, Collegeville, PA,
Abstract
The impact on hospice quality after initiation of an internal palliative care program by a community oncology practice.Org: Virginia Cancer Institute, Integra Connect, Everett Castle, LLC,
Abstract
Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer.Org: Precision Q, Integra Connect, GSK Research and Development Upper Providence, Collegeville, PA, South Carolina Oncology Associates,
Abstract
Effect of testing for BRCA1/2 on outcomes in patients with ovarian cancer treated with PARPi in 1st line maintenance (1LM).Org: Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, Integra Connect PrecisionQ, Illumina, Inc., Integra Connect,
Abstract
The impact of receipt of systemic anticancer therapy (SACT) near the end of life (EOL) on cost among oncology practices participating in CMS' Oncology Care Model (OCM).Org: Yale School of Medicine, Everett Castle, LLC, Integra Connect, Yale University,